JHS Svendgaard Laboratories Ltd

JHS Sven.Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

JHS Svendgaard Laboratories Ltd

₹ 17.0 0.00%
06 Jun 2:11 p.m.
svendgaard.com BSE: 532771 NSE : JHS
About

JHS Svendgaard Laboratories Limited is engaged in manufacturing a range of oral and dental products for elite national and international brands. [1]

Key Points

Products
The company’s product portfolio includes Toothbrush, Toothpaste, Mouthwash, Laundry detergent, Hand sanitizer, soap bars, shampoos, handwashes, cream, snacks, talcum powder and washing powder. [1]

Website BSE NSE
  • Market Cap ₹ 110 Cr.
  • Current Price ₹ 17.0
  • High / Low ₹ 28.1 / 13.6
  • Stock P/E 68.4
  • Book Value ₹ 26.6
  • Dividend Yield 0.00 %
  • ROCE -1.18 %
  • ROE 0.90 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 0.67 times its book value
  • Debtor days have improved from 123 to 78.4 days.
  • Company's working capital requirements have reduced from 184 days to 51.5 days

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -7.27% over past five years.
  • Company has a low return on equity of -0.14% over last 3 years.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: FMCG Industry: Personal Care - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
41 17 32 27 25 22 25 21 19 21 24 25 25
40 20 29 25 25 22 24 22 19 23 27 27 28
Operating Profit 2 -3 3 2 0 -1 1 -1 -0 -1 -2 -2 -3
OPM % 4% -17% 9% 7% 0% -3% 5% -5% -1% -7% -10% -7% -11%
-3 2 0 1 4 3 2 3 2 1 3 2 -11
Interest 0 0 0 0 0 0 0 0 1 1 0 0 0
Depreciation 2 2 2 2 2 2 2 2 2 2 2 2 2
Profit before tax -4 -3 1 0 3 -0 1 -0 -0 -2 -1 -2 -16
Tax % 34% 22% 26% 75% -13% -80% 34% 92% -7,300% -76% 58% 2% 38%
Net Profit -3 -2 1 0 3 -0 0 -0 -4 -4 -0 -2 -10
EPS in Rs -0.30 -0.41 0.16 0.02 0.41 -0.04 0.04 0.04 -0.67 -0.59 -0.03 -0.24 -1.52
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
127 60 35 55 100 104 140 124 139 101 86 96
110 48 39 59 93 92 126 124 137 99 87 105
Operating Profit 16 12 -4 -4 7 12 14 0 2 2 -1 -9
OPM % 13% 20% -11% -7% 7% 11% 10% 0% 1% 2% -1% -9%
1 12 -3 -6 -17 0 32 6 3 7 9 -4
Interest 6 10 14 0 0 1 1 1 2 1 1 1
Depreciation 7 14 15 12 10 6 7 7 9 7 7 7
Profit before tax 3 0 -35 -22 -22 5 38 -2 -6 1 0 -22
Tax % 66% 1,357% 18% -0% 0% -327% 32% 19% 17% -39% 4,000% 23%
Net Profit 1 -4 -29 -22 -22 22 26 -2 -5 1 -4 -17
EPS in Rs 0.63 -1.56 -11.96 -9.21 -5.75 4.97 4.29 -0.11 -0.33 0.19 -0.62 -2.38
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 5%
5 Years: -7%
3 Years: -12%
TTM: 12%
Compounded Profit Growth
10 Years: 8%
5 Years: -27%
3 Years: 1%
TTM: 145%
Stock Price CAGR
10 Years: 4%
5 Years: -18%
3 Years: 10%
1 Year: -32%
Return on Equity
10 Years: -1%
5 Years: 0%
3 Years: 0%
Last Year: 1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
18 24 24 24 38 44 61 61 61 64 65 65
Reserves 97 65 38 96 57 86 113 116 117 124 121 108
67 101 54 19 3 2 2 7 9 7 6 3
52 41 74 33 25 23 32 39 55 33 30 60
Total Liabilities 233 232 190 171 122 155 208 223 241 228 222 236
52 135 121 108 65 65 71 71 66 63 59 66
CWIP 24 0 0 0 1 1 1 5 7 9 20 9
Investments 0 0 0 0 0 1 18 10 6 2 4 4
157 97 70 63 57 89 118 137 163 154 140 157
Total Assets 233 232 190 171 122 155 208 223 241 228 222 236

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-12 60 28 7 -4 -4 14 -11 10 12 -9 19
-26 -22 3 1 1 -3 -27 -7 -11 -2 -5 6
37 -39 -29 -10 4 10 14 13 0 10 -2 8
Net Cash Flow -1 -2 2 -1 2 3 0 -5 -0 20 -16 33

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 295 220 188 167 25 48 111 158 252 213 77 78
Inventory Days 54 132 122 94 53 95 65 60 30 97 114 76
Days Payable 180 407 95 106 67 123 153 134 177 128 130 118
Cash Conversion Cycle 170 -55 215 156 12 19 23 85 105 182 61 36
Working Capital Days 201 29 -368 84 59 56 122 187 202 277 222 52
ROCE % 6% 1% -10% -12% -3% 5% 8% -0% 4% 1% 1% -1%

Shareholding Pattern

Numbers in percentages

Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
44.17 44.17 44.17 41.77 41.77 41.77 41.77 42.23 42.23 42.23 42.23 42.23
0.49 0.49 0.49 0.47 0.39 0.00 0.04 0.18 0.00 0.00 0.00 0.00
55.34 55.34 55.34 57.77 57.84 58.23 58.20 57.59 57.77 57.77 57.78 57.78

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls